Pharmacists in Port Charlotte, Florida


76 Pharmacists found in Port Charlotte
male pharmacist

Ronald D Heon, RPH


Pharmacist
18087 York Ave, Port Charlotte, FL 33948
941-258-2602    

female pharmacist

Ruth Elizabeth Fishman, PHARM D


Pharmacist
1400a Tamiami Trl, T-0690, Port Charlotte, FL 33948
941-255-1682     941-255-1682

female pharmacist

Ms. Sandra L Stites, RPH


Pharmacist
24123 Peachland Blvd, Port Charlotte, FL 33954
941-627-5704     941-625-1986



male pharmacist

Sean Fernberg, PHARM D


Pharmacist
3370 Tamiami Trl, Port Charlotte, FL 33952
941-979-9085     941-979-8146

female pharmacist

Shirley Peeples Mccarty, RPH


Pharmacist
13435 Mccall Rd, Port Charlotte, FL 33981
941-697-7826     941-697-7826

female pharmacist

Soni Pious


Pharmacist
1930 Kings Hwy, Port Charlotte, FL 33980
941-764-8444    

female pharmacist

Dr. Sophia Kuma, PHARM.D.


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
2500 Harbor Blvd, Port Charlotte, FL 33952
941-766-4122    

male pharmacist

Stephen R Kramny, RPH


Pharmacist
4222 Gardner Dr, Port Charlotte, FL 33952
941-321-7860    

female pharmacist

Tran Bui, PHARMD


Pharmacist - Pharmacotherapy
3280 Tamiami Trl, Port Charlotte, FL 33952
941-625-2518    

female pharmacist

Valeria Fogel, PHARM D


Pharmacist
21297 Olean Blvd Unit B, Port Charlotte, FL 33952
941-766-1584     941-249-4609

male pharmacist

Victor Leonard Sabarese, RPH


Pharmacist
24128 Green Heron Dr, Port Charlotte, FL 33980
724-263-5195    

female pharmacist

Victoria Marie Sweet


Pharmacist
4265 Tamiami Trl, Port Charlotte, FL 33980
941-629-0084    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.